Eli Lilly is the leader in GLP-1 weight loss drugs today, but that advantage won't last forever.

In the latest trading session, Eli Lilly (LLY) closed at $1,064.29, marking a -2.12% move from the previous day. This change lagged the S&P 500's 0.03% gain on the day. Elsewhere, the Dow saw a ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

It feels like a great rotation out of the Magnificent Seven has already kicked off just over a quarter ago. Undoubtedly, the ...

My top 10 things to watch Tuesday, Jan. 27 1. The S & P 500 was headed for a slightly higher open this morning ahead of Big Tech earnings tomorrow evening (Meta Platforms and Microsoft ) and Thursday ...

Eaton Vance Enhanced Equity Income Fund is a Strong Buy for superior balance of yield & total return in covered call space.

The S&P 500 advanced this morning as Wall Street cheered signs of easing geopolitical tensions. Traders are also awaiting key inflation data.

The American Century U.S. Quality Growth ETF offers exposure to highly profitable companies with growth characteristics. Read ...

Stocks in this week’s article are Royal Gold RGLD, NVIDIA NVDA, Expedia Group EXPE and Amphenol APH. 4 GARP Stocks that ...

The Vanguard Growth ETF has a stellar track record against the S&P 500 thanks to its unique portfolio.

Both companies may succeed in this industry.

This biotech has candidates in late-stage clinical development.